LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy
Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant
Dr Judith Cohen J.Cohen@hull.ac.uk
Director, Hull Health Trials Unit
|Funder(s)||Blood Cancer UK|
|Project Dates||Jun 1, 2018 - Feb 28, 2022|
You might also like
BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual pr... Read More about BREATHE: Breathlessness RElief AT HomE.
CLL Research Jan 26, 2015 - Dec 31, 2025
Translational research project utilising prospective sample collection from patients attending the Haematology Clinic, Hull university Teaching Hospital Trust, to facilitate research within the University of Hull.
MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness Mar 1, 2019 - Feb 29, 2024
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with c... Read More about MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness.
STATIC: A Randomised Phase III Trial Comparing Continuous with Intermittent Treatment Strategies in Chronic Lymphocytic Leukaemia (CLL) Jan 1, 2021 - Mar 31, 2031
Chronic lymphocytic leukaemia (CLL) is a cancer that affects the blood and bone marrow. It tends to progress slowly, and is incurable. CLL is the most common leukaemia in adults. The first treatment for CLL is chemotherapy. This is usually given for... Read More about STATIC: A Randomised Phase III Trial Comparing Continuous with Intermittent Treatment Strategies in Chronic Lymphocytic Leukaemia (CLL).